Our Products for Overseas Market
Freeze-Dried BCG Vaccine for Intradermal Use
| Product |
Pack of 100 ampoules each containing 0.5mg BCG(as wet weight with 70% of water content) plus pack of 100 ampoules each containing 1.0 mL diluent |
| Indication |
For active immunization against tuberculosis |
| Administration |
-Younger than 1 year :
Single dose of 0.05 mL intradermally
-Aged 1 year or older :
Single dose of 0.1 mL intradermally |
| storage |
2℃-8℃, protected from sunlight |
Freeze-Dried BCG Vaccine for Percutaneous Use
| Product |
1 ampoule containing 12 mg BCG (as wet weight with 70% of water content) plus 1 ampoule containing 0.15 mL diluent |
| Indication |
For active immunization against tuberculosis |
| Administration |
Instill reconstitution onto the central area of the lateral aspect of the arm, using a multi-puncture device(percutaneous 9-needle vaccinator) |
| storage |
10℃ or less, protected from sunlight |
Freeze-Dried Tuberculin, Purified Protein Derivative(PPD)
| Product |
Box containing 10 vials and 10 ampoules. Each vial contains 1 µg of PPD (equivalent to 50 tuberculin units).Each ampoule contains 2 mL diluent |
| Indication |
Intradermal Mantoux test for the diagnosis of tuberculosis infection |
| Administration |
Skin test with 2.5 TU Reconstitute powder with 2 mL diluent |
| storage |
Store dry powder at 2℃-8℃ Reconstituted powder is stable for 2 weeks if stored at 2℃-8℃ without contamination and protected from sunlight. |
Immunobladder® Intravesical
| Product |
1 vial containing 80 mg BCG(as wet weight with 70% of water content) plus 1 ampoule containing 2 mL diluent |
| Indication |
Treatment of TaT1 papillary tumors and carcinoma in situ(CIS) of the urinary bladder |
| Administration |
A urethral catheter is inserted into the bladder under aseptic conditions, the bladder is drained, and then the suspension is instilled slowly by gravity |
| storage |
10℃ or less, protected from sunlight |
